Related Experiment Video
Updated: Jan 5, 2026

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
Published on: February 24, 2014
Distress in post-treatment hematological cancer survivors: Prevalence and predictors
Deborah Raphael1, Rosemary Frey1, Merryn Gott1
1School of Nursing, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
Abstract:
Objectives: To calculate the prevalence of psychosocial distress, and identify factors that predict distress, in early post-treatment hematological cancer survivors.Design: Cross-sectional survey containing self-report measures.Sample/Methods: Post-treatment hematological cancer survivors in remission (>18 years) (n = 409) completed questionnaires. Distress was measured with the distress thermometer (DT). Logistic regression was used to identify predictors of distress.Findings: Overall 21.9% (n = 93) of respondents reported significant distress (DT ≥4). Significant distress was twice as high in those born overseas (OR = 2.09, p = .03), 3.5 times higher in those with lower social support (OR = 3.51, p = <.001) and five times higher in those with increased fear of recurrence (OR = 0.17, p = <.001).Implications for Psychosocial Providers: Early identification of distress may decrease psychosocial issues in the post-treatment period, especially as psychosocial services have been shown to improve wellbeing for those who are distressed.
Related Concept Videos
Treatment Resistant Cancers
Cancer Survival Analysis
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
